Mohammad A Alqudah
Overview
Explore the profile of Mohammad A Alqudah including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
77
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alqudah M, Zayed M, Subzar M, Wani S
Heliyon
. 2024 Apr;
10(8):e28934.
PMID: 38681655
Various authors have put their sincere efforts into proposing ratio estimators for estimating the population's mean and variance under different situations and sampling methods. But the problem arises when data...
2.
Al-Keilani M, Alqudah M, Almomani B, Alrjoub M, Shhabat B, Alzoubi K
Curr Cancer Drug Targets
. 2023 Aug;
23(10):805-816.
PMID: 37638596
Background: Neovascularization is essential for the growth and progression of tumor tissues. GRP78 is frequently overexpressed in various cancers and has been suggested as a proangiogenic factor. Purpose: This study...
3.
Alqudah A, Qnais E, Wedyan M, AlKhateeb H, Abdalla S, Gammoh O, et al.
Heliyon
. 2023 May;
9(4):e15619.
PMID: 37151635
Background: Lysionotin, a natural flavonoid extracted from Maxim (Gesneriaceae), has several pharmacological effects including anti-bacterial, anti-hypertensive and anti-inflammatory effects. However, its analgesic effect has not been investigated. This study aimed...
4.
Al-Keilani M, Bdeir R, Elstaty R, Alqudah M
BMC Cancer
. 2023 Feb;
23(1):158.
PMID: 36797689
Background: Chronic inflammation is a hallmark of cancer, and it can be stimulated by many factors. Substance P (SP), through binding to neurokinin 1 receptor (NK1R), and pyruvate kinase M2...
5.
Alqudah M, Hamouri S, Haddad H, Tawalbeh R, Haddad H
Future Sci OA
. 2022 Dec;
8(8):FSO814.
PMID: 36457542
Benign metastasizing leiomyoma (BML) is a rare pathological process associated with pelvic leiomyoma. We present two cases of BML that are associated with giant pulmonary metastasis. BML is a rare...
6.
Al-Keilani M, Elstaty R, Alqudah M
Int J Breast Cancer
. 2022 Apr;
2022:4987912.
PMID: 35419208
Background: Neurokinin 1 receptor (NK1R) is a promising biomarker and therapeutic target in breast cancer. This study was aimed at investigating the expression level of NK1R in breast cancer tissues...
7.
Abdulrazeq F, Kheirallah K, Al-Mistarehi A, Al Bashir S, Alqudah M, Alzoubi A, et al.
PeerJ
. 2022 Feb;
10:e12824.
PMID: 35116201
Background: Stem cell science is rapidly developing with the potential to alleviate many non-treatable diseases. Medical students, as future physicians, should be equipped with the proper knowledge and attitude regarding...
8.
Khader E, Ismail W, Mhaidat N, Alqudah M
Int J Health Sci (Qassim)
. 2021 Sep;
15(5):34-41.
PMID: 34548861
Objectives: Metformin is widely used for the treatment of type 2 diabetes mellitus and found to have a crucial rule in the induction of apoptosis in several cancer types including...
9.
Al-Keilani M, Elstaty R, Alqudah M, Alkhateeb A
PLoS One
. 2021 Jun;
16(6):e0252616.
PMID: 34086748
Background: The neuropeptide substance P is a potential biomarker and therapeutic target in cancer. The main objectives of this study were to investigate the expression level of substance P in...
10.
Alqudah M, Alfaqih M, Hamouri S, Al-Shaikh A, Haddad H, Al-Quran W, et al.
Ann Med Surg (Lond)
. 2021 May;
65:102330.
PMID: 33996061
Background: Lung cancer is a major health burden in Jordan. With the failure of tobacco control policies and the evolution of new smoking methods like water pipes and e-cigarettes, lung...